GLP-1 receptor agonists modulate blood glucose levels in T2DM by affecting Faecalibacterium prausnitzii abundance in the intestine

BACKGROUND: Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of medications used to treat type 2 diabetes, including metformin, which is considered first-line therapy for type 2 diabetes. In recent years, GLP-1 receptor agonists (GLP-1 RAs) have been found to alter the composition and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Lei, Rao, Elizabeth, Zhang, Xuxiang, Wu, Bin, Su, Xiaoyun, Chen, Lin, Nie, Rong, Nian, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476738/
https://www.ncbi.nlm.nih.gov/pubmed/37657059
http://dx.doi.org/10.1097/MD.0000000000034978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476738/
https://www.ncbi.nlm.nih.gov/pubmed/37657059
http://dx.doi.org/10.1097/MD.0000000000034978

Ejemplares similares